10.1016/j.jbc.2024.107294 145
Overall Adverse Event Rates Dose Group Any Adverse Event (%) GI Adverse Events (%) Discontinuation Due to AE (%) Placebo 72.1% 32.6% 0% 1 mg 88.6% 48.6% 2.9% 4 mg (escalated) 88.6% 60.0% 5.7% 4 mg (single dose) 90.9% 63.6% 6.1% 8 mg (escalated) 87.5% 57.5% 5.0% 8 mg (single dose) 88.6% 62.9% 5.7% 12 mg (escalated) 97.2% 66.7% 8.3% Source: Jastreboff AM, Kaplan LM, Fras JP, et al
For those patients, we offer options to make the process more comfortable
Compounded medications are non-FDA-approved preparations and are not generic versions of, nor the same as, Ozempic, Wegovy, Mounjaro, or Zepbound
The dosing miscommunications, shipping delays, and customer service gaps documented in negative reviews represent real problems that affect a meaningful minority of customers